- Home
- MRKR vs YMAT Comparison
MRKR vs YMAT Comparison
Compare MRKR & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRKR | YMAT |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 14.4M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | MRKR | YMAT |
|---|---|---|
| Price | $1.82 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.17 | N/A |
| AVG Volume (30 Days) | ★ 466.1K | 106.6K |
| Earning Date | 11-13-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,694,988.00 | ★ $20,054,081.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.49 |
| Revenue Growth | N/A | ★ 11.79 |
| 52 Week Low | $0.81 | $0.40 |
| 52 Week High | $4.07 | $6.45 |
Technical Indicators
Market Signals| Indicator | MRKR | YMAT |
|---|---|---|
| Relative Strength Index (RSI) | 58.74 | N/A |
| Support Level | $1.64 | N/A |
| Resistance Level | $2.46 | N/A |
| Average True Range (ATR) | 0.21 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 40.00 | 0.00 |
Price Performance
Historical ComparisonAbout MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About YMAT J-Star Holding Co. Ltd. Ordinary Shares
J Star Holding Co Ltd is engaged in the research, development and manufacturing of carbon fiber for a wide variety of products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products.